ASKA Pharmaceutical is committed to advancing healthcare through innovative research and development, particularly in the fields of internal medicine, obstetrics and gynecology, and urology. The company emphasizes the importance of addressing unmet medical needs by leveraging its extensive experience in sex hormones and endocrinology. ASKA has established a research center at the Shonan Health Innovation Park to foster collaboration and adapt to rapid technological advancements. This strategic move enhances their ability to develop high-value drugs and engage in forward-looking alliances with both domestic and international partners, aiming to expedite the delivery of new treatments to patients.

In addition to its research initiatives, ASKA Pharmaceutical maintains a robust production framework that adheres to Good Manufacturing Practice (GMP) standards. The company operates a comprehensive quality control system at its Iwaki Factory, which includes the recent addition of a fourth manufacturing building. This infrastructure supports ASKA's goal of ensuring a stable supply of high-quality pharmaceuticals while continuously innovating to improve productivity and reduce costs. The company’s commitment to ethical research practices is evident in its adherence to regulations governing animal welfare and its establishment of internal committees to oversee ethical considerations in research involving human tissue and genetic studies.

Japan

ASKA Pharmaceutical Co., Ltd. is a leading company in the field of Thyroid disease by through supplying a variety of medicines.

Furthermore, we utilize our hormonal technology, aim to contribute all patients for obstetrics and gynecology area.

ASKA Pharmaceutical

Company Details